Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects*; D002395:Catecholamines / Q000097:blood / Q000378:metabolism* / Q000652:urine; D005260:Female; D016316:Guanfacine; D006146:Guanidines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010648:Phenylacetates / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D012083:Renin / Q000097:blood*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*; D013997:Time Factors
D000959:Antihypertensive Agents; D002395:Catecholamines; D006146:Guanidines; D010648:Phenylacetates; D016316:Guanfacine; D012083:Renin